Ceapro Reports 2018 First Quarter Results

12:07 EDT 17 May 2018 | Investing News Network

Ceapro (TSX-V:CZO) a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced financial results and operational highlights for the quarter ended March 31, 2018. As quoted in the press release: “The exciting evolution of Ceapro has continued in 2018. While we continue to leverage on our de-risked … Continued

The post Ceapro Reports 2018 First Quarter Results appeared first on Investing News Network.

Original Article: Ceapro Reports 2018 First Quarter Results


More From BioPortfolio on "Ceapro Reports 2018 First Quarter Results"

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...